🇺🇸 FDA

Intelligence · Patent portfolio

United Therapeutics Europe Patents

Full USPTO pharma patent portfolio for United Therapeutics Europe — grant dates, expiration, and drug cross-links.

Patents
3,720
Expiring ≤24m
234

Quick answer

United Therapeutics Europe has 3,720 pharmaceutical patents in our USPTO PatentsView index (A61K/A61P). 234 expire within 24 months — use filters for patent-cliff planning.

Page 34 of 78

  1. US 9346875

    Therapy for filovirus infection

    Expires Mon May 19 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. US 9345758

    Materials and methods for respiratory disease control in canines

    Expires Mon May 19 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  3. US 9339507

    Treprostinil administration by inhalation

    Expires Mon May 12 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  4. US 9341619

    Hyposialylation disorders

    Expires Mon May 12 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  5. US 9334246

    Substituted triazines for malaria treatment and chemoprophylaxis

    Expires Mon May 05 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  6. US 9334522

    Agents and methods to elicit anti-tumor immune response

    Expires Mon May 05 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  7. US 9333237

    Bone morphogenic protein binding peptide

    Expires Mon May 05 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  8. US 9333251

    Vaccine for protection against Shigella sonnei disease

    Expires Mon May 05 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  9. US 9326978

    A3 adenosine receptor allosteric modulators

    Expires Mon Apr 28 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  10. US 9326950

    Self-assembling nanoparticles composed of transmembrane peptides and their application for specific intra-tumor delivery of anti-cancer drugs

    Expires Mon Apr 28 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  11. US 9328150

    Recombinant polypeptide construct comprising multiple enterotoxigenic Escherichia coli fimbrial subunits

    Expires Mon Apr 28 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  12. US 9327031

    Buffer solutions having selective bactericidal activity against gram negative bacteria and methods of using same

    Expires Mon Apr 28 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  13. US 9328391

    Cloning and expression of HIV-1 DNA

    Expires Mon Apr 28 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  14. US 9326992

    Methods for treating progeroid laminopathies using oligonucleotide analogues targeting human LMNA

    Expires Mon Apr 28 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  15. US 9328142

    Lipopeptide inhibitors of RAS oncoproteins

    Expires Mon Apr 28 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  16. US 9320786

    Plasmodial surface anion channel inhibitors for the treatment or prevention of malaria

    Expires Mon Apr 21 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  17. US 9320789

    Combinations of gene deletions for live attenuated shigella vaccine strains

    Expires Mon Apr 21 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  18. US 9321834

    Anti-malarial compositions

    Expires Mon Apr 21 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  19. US 9321128

    High power laser system

    Expires Mon Apr 21 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  20. US 9315826

    Nucleic acids containing a synthetic codon-optimized Sin Nombre virus full-length M gene

    Expires Mon Apr 14 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  21. US 9314448

    Method of inhibiting ABCG2 and other treatment methods

    Expires Mon Apr 14 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  22. US 9314494

    Cranberry xyloglucan oligosaccharide composition

    Expires Mon Apr 14 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  23. US 9316646

    Anti-human ROR1 antibodies

    Expires Mon Apr 14 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  24. US 9314532

    Drug delivery vehicle

    Expires Mon Apr 14 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  25. US 9308246

    Capsule composition for use as immunogen against Campylobacter jejuni

    Expires Mon Apr 07 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  26. US 9308163

    Methods of treating and preventing diseases and disorders of the central nervous system

    Expires Mon Apr 07 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  27. US 9309237

    HIV inhibitors

    Expires Mon Apr 07 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  28. US 9310368

    High affinity monoclonal antibodies for detection of Shiga toxin 2 (STX2)

    Expires Mon Apr 07 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  29. US 9303080

    Codon optimized IL-15 and IL-15R-alpha genes for expression in mammalian cells

    Expires Mon Mar 31 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  30. US 9303044

    7-(piperazin-1-yl)-5H-[1,3,4]thiadiazolo[3,2-A]pyrimidin-5-ones for the treatment of thrombotic disorders

    Expires Mon Mar 31 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  31. US 9304124

    Compact multifunctional ligand to enhance colloidal stability of nanoparticles

    Expires Mon Mar 31 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  32. US 9296729

    Low molecular weight thyroid stimulating hormone receptor (TSHR) agonists

    Expires Mon Mar 24 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  33. US 9296790

    Methods and compositions for protein delivery

    Expires Mon Mar 24 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  34. US 9295754

    Noggin inhibitory compositions for ossification and methods related thereto

    Expires Mon Mar 24 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  35. US 9295659

    High dose extended-release potassium citrate wax matrix tablet

    Expires Mon Mar 24 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  36. US 9290512

    Activators of human pyruvate kinase

    Expires Mon Mar 17 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  37. US 9284356

    Identification of a west nile virus CD4 T cell epitope and use thereof

    Expires Mon Mar 10 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  38. US 9283233

    Method for on-demand contraception

    Expires Mon Mar 10 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  39. US 9278901

    Compounds and methods for delivery of prostacyclin analogs

    Expires Mon Mar 03 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  40. US 9279019

    Human monoclonal antibodies specific for CD22

    Expires Mon Mar 03 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  41. US 9278110

    Anti-regurgitation and/or anti-gastrooesophageal reflux composition, preparation and uses

    Expires Mon Mar 03 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  42. US 9277748

    Agonist/antagonist compositions and methods of use

    Expires Mon Mar 03 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  43. US 9279009

    FILIP1L nucleic acid fragments

    Expires Mon Mar 03 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  44. US 9277799

    Henna applicator device and a method of operating the same

    Expires Mon Mar 03 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  45. US 9278090

    Methods of preventing the development of mucositis and related disorders

    Expires Mon Mar 03 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  46. US 9278089

    Method of treating HCV infection with a small molecule CHK2 inhibitor

    Expires Mon Mar 03 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  47. US 9272009

    Method for increasing performance of offspring

    Expires Mon Feb 25 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  48. US 9272023

    Use of ixolaris, a tissue factor inhibitor, for inhibiting angiogenesis

    Expires Mon Feb 25 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

How many patents does United Therapeutics Europe have?

3,720 published patents match the current filter (all indexed). The full portfolio is indexed from USPTO PatentsView (A61K/A61P).

When do United Therapeutics Europe patents expire?

234 patents in the full portfolio expire within 24 months. Use the expiring filters above or open individual patent pages for grant and expiration dates.

Where does this data come from?

USPTO PatentsView bulk data filtered to pharmaceutical CPC classes (A61K, A61P), cross-linked to NovaPharmaNews company and drug profiles. See our data sources page for methodology.

Data attribution: Data sources · Patent directory

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.